Sivakumar Ganesan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The discovery of a back-up to the hepatitis C virus NS3 protease inhibitor asunaprevir (2) is described. The objective of this work was the identification of a drug with antiviral properties and toxicology parameters similar to 2, but with a preclinical pharmacokinetic (PK) profile that was predictive of once-daily dosing. Critical to this discovery process(More)
  • 1